investorscraft@gmail.com

Intrinsic Value of Apollo Endosurgery, Inc. (APEN)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2022-12-31.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %22.0NaN
Revenue, $77NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m108NaN
Operating income, $m-31NaN
EBITDA, $m-28NaN
Interest expense (income), $mNaN
Earnings before tax, $m-39NaN
Tax expense, $m1NaN
Net income, $m-40NaN

BALANCE SHEET

Cash and short-term investments, $m57NaN
Total assets, $m110NaN
Adjusted assets (=assets-cash), $m53NaN
Average production assets, $m16NaN
Working capital, $m53NaN
Total debt, $m54NaN
Total liabilities, $m78NaN
Total equity, $m33NaN
Debt-to-equity ratio1.647NaN
Adjusted equity ratio-0.088NaN

CASH FLOW

Net income, $m-40NaN
Depreciation, amort., depletion, $m3NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-31NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-2NaN
Free cash flow, $m-29NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m53
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount